Netherlands· NL-01b2a4b68c4e

Reyataz 150 mg, harde capsules

A atazanavir product containing atazanavirsulfaat, registered in Netherlands by Bristol-Myers Squibb Pharmaceuticals Limited. The same ATC class is registered in 17 of our 19 countries.

ATC J05AE08

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about atazanavirsulfaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Atazanavir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AE08 (atazanavir), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search atazanavir products by name

Atazanavir · ATC J05AE08

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of atazanavir costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Atazanavir · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$14.11

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ATAZANAVIRSULFAAT
Manufacturer: Bristol-Myers Squibb Pharmaceuticals Limited
Country: Netherlands (NL)
ATC code: J05AE08
ATC class: Atazanavir
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/03/267

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

429 interactions on record for atazanavir.

Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check atazanavir against other medicines How interaction checks work

Atazanavir · interactions on record

429 records

135 severe
204 moderate
14 minor
50 info

Most severe, free to view

CimetidineA02BA01severe
RanitidineA02BA02severe
FamotidineA02BA03severe
NizatidineA02BA04severe

26 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Atazanavir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atazanavir products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

Cyprus · Atazanavir Remedica
Czechia · Atazanavir Accord
Germany · Atazanavir Accord, Atazanavir Al
Denmark · Atazanavir Stada
Spain · Atazanavir Stada, Atazanavir Teva
Finland · Atazanavir Stada
France · Atazanavir Arrow, Atazanavir Biogaran
United Kingdom (Northern Ireland) · Atazanavir Accord, Atazanavir Amarox
Croatia · Atazanavir Accord
Ireland · Atazanavir Rowex
Iceland · Atazanavir Stada, Atazanavir Stada 150 Mg Hörð Hylki
Italy · Atazanavir Sandoz
Liechtenstein · Atazanavir Viatris, Reyataz
Latvia · Atazanavir Sandoz
Norway · Atazanavir Viatris, Reyataz
Portugal · Atazanavir Farmoz, Atazanavir Generis
Romania · Atazanavir Stada, Atazanavir Teva
Sweden · Atazanavir Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ab7bcac2-13e4-4212-84e2-0ac4d36f7576
GET /v1/drugs/ab7bcac2-13e4-4212-84e2-0ac4d36f7576?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/reyataz-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Atazanavir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71754",
  "excipients": [
    "AMMONIA (E 527)",
    "AMMONIA (E 527)",
    "BLAUWE INKT",
    "CROSPOVIDON (E 1202)",
    "GELATINE (E 441)",
    "INDIGOKARMIJN (E 132)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "SIMETICON",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "WITTE INKT"
  ],
  "substances": [
    "ATAZANAVIRSULFAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2004/03/02",
  "procedure_number": "EMEA/H/C/000494",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/03/267",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about atazanavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console